Skip to main content
TrialFinder
ResourcesAbout
ⓘNot medical advice.▾

This site is for general information only and is not medical advice, diagnosis, or treatment. Always talk to a qualified clinician before medical decisions. TrialFinder is not affiliated with trial sponsors or healthcare providers.

Privacy policyTerms of useAccessibilityFAQFeedback
Support the project (opens in a new tab)

We use functional cookies to improve your experience. See our Privacy policy.

Trial data comes from ClinicalTrials.gov (US) and is shown for information only.

In memory of Dov Korn ❤️

Not a Perfect Match? Tips for Getting Into a Clinical Trial Anyway | TrialFinder
HomeResourcesNot a Perfect Match? Tips for Getting Into a Clinical Trial Anyway

Back to Resources

Published · May 5, 2026

Not a Perfect Match? Tips for Getting Into a Clinical Trial Anyway

You found a trial, but the fit isn't perfect. Or you applied and got a "no." Now what?

You've done the work. You searched, found a trial that looked right, maybe even discussed it with your treating doctor or specialist. But something doesn't line up: a lab result might not match what the protocol requires, a previous treatment might disqualify you, your physical condition (ECOG score) is borderline, or the recruiting window just closed. Maybe you already applied and got rejected.

This can be devastating. But an imperfect match or a "no" doesn't always mean the end. The system has more flexibility than most people realize, and there are practical steps you can take.

Retest the problematic results

If you were disqualified based on a specific test result (blood markers, imaging, ECOG score), ask your doctor whether it makes sense to repeat the test. Results can sometimes vary between measurements. A borderline ECOG score of 2 might come back as 1 on a better day. Blood markers can fluctuate. It's not guaranteed, but it's worth asking.

Ask your doctor to contact the lead researcher directly

The lead researcher (principal investigator) at each trial site is a doctor, sometimes a senior oncologist at a hospital near you, sometimes at a different medical center. A doctor-to-doctor conversation carries different weight than a patient reaching out to a research team. Your doctor can call the PI and discuss your specific case. This is how many borderline cases get resolved. Don't be shy about asking your doctor to make that call.

Reach out to the lead researcher yourself

If your doctor's outreach didn't work, or if you want to try in parallel, find the principal investigator at the trial site. They are a physician running the study—not someone you should count on sorting everything out from a cold email. What is more likely to help is talking with them through normal clinical routes: their hospital clinic, a referral arranged by your doctor, or a private consultation if that is an option where you live.

If the trial that could help you is based at a major hospital and you are being treated in the community or at a smaller center, consider booking an appointment with the PI or their team there. If they agree you may be a fit, it may mean transferring your care to that hospital. That's a big step, but when the alternative is no trial at all, it can be worth it.

Contact the pharmaceutical company

The company sponsoring the trial has a medical affairs team. While the chances are lower, contacting them can sometimes open doors. If you have any connections to people in the pharmaceutical industry, even distant ones, this is the time to use them.

When reaching out to the pharma company or the lead researcher, also ask about two specific options:

Compassionate use (expanded access). This is a separate regulatory pathway where a company provides an experimental drug outside of the formal trial for patients who don't meet the criteria or whose trial site isn't available. Your doctor can help initiate this request.

Similar trials. The same drug might be tested in a different trial with slightly different eligibility criteria that you do meet. Or the same trial might be running at a different site that's still recruiting when yours has closed. Ask the company or the PI whether there are alternative pathways to the same treatment.

Join an observational study as a stepping stone

For rare diseases especially, enrolling in a Natural History study (an observational study that tracks how a disease progresses) can put you on the researchers' radar. When a treatment trial opens later, patients already enrolled in related studies are often the first to be invited.

Explore through your health system, insurer, or national service

What is available depends on the country. Your GP or primary care team, insurer, or national health service may know about relevant studies, help with referrals to research-active hospitals, or offer navigation support—for example, specialist teams within the NHS in the UK sometimes help patients find trials. Ask what your local system can do before you assume there is no door there.

A "no" is not always final

The system is complex, and the rules are strict for good reason, they protect patients. But within that system, there is more flexibility than most people realize. A rejection from one trial, one site, or one moment in time doesn't mean the door is closed forever.

Keep searching. Keep asking. And take care of yourself and your family along the way.

Further reading

Osimertinib for Uncommon EGFR Mutations: What the Evidence Shows Osimertinib (Tagrisso) for uncommon EGFR mutations such as G719X, S768I, L861Q, and exon 20 insertions: what the evidence covers, plus active clinical trials.

Clinical Trials in Mental Health: What Patients and Families Should Know Mental health clinical trials can test medications, psychotherapy, TMS devices, digital therapeutics, and psychedelic-assisted treatment. Here is how they differ from cancer trials, and how to start looking.

Before You Join a Clinical Trial: Screening, Informed Consent, and Red Flags What happens between finding a clinical trial and your first visit: screening, the informed consent form, the questions worth asking, common fears answered plainly, and the red flags that should make you walk away.

The Reminder Moderna and Merck's Personalized mRNA Cancer Vaccine Gives Us About Clinical Trials Moderna and Merck's personalized mRNA cancer vaccine just hit its Phase 3 endpoints in melanoma. Here's what it teaches us about the value of joining clinical trials.

Breakthrough in Pancreatic Cancer: Compassionate Use for KRAS Mutations Explained
The new drug Daraxonrasib showed impressive survival results for eligible pancreatic cancer patients. It is currently available via compassionate use. Here is what you need to know.

How to Talk to Your Doctor About Clinical Trials What questions should you ask your doctor about clinical trials? A step-by-step guide for patients: when to bring it up, what to prepare, and what to do after.

Start Here: How to Search for Clinical Trials on TrialFinder A step-by-step guide to finding clinical trials on TrialFinder. Learn how to search by condition, use filters, and understand your results.

What is a Clinical Trial? (It's More Than You Think) How clinical trials work, why they matter, and what patients should know before considering one.

How to Talk About Clinical Trials with a Family Member A guide for caregivers on introducing clinical trials to a loved one who is hesitant, tired, or afraid.

Key Clinical Trial Terms Plain-language explanations of terms patients and families encounter during the clinical trial process.

Share this post
  •  

This article was written by a patient advocate based on personal experience, not by a medical professional. It is not medical advice. Consult your doctor before making any medical decisions.

Looking for a clinical trial?

Search trials